Acadia Investor Says Officers Overhyped Drug's Prospects

By Emilie Ruscoe · December 19, 2023, 7:39 PM EST

An investor in biopharmaceutical company Acadia Pharmaceuticals Inc. has filed a derivative shareholder suit against the company's brass in San Diego federal court alleging the executives misrepresented its chances of receiving...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Kanner et al v. Biggar et al

Case Number

3:23-cv-02293

Court

California Southern

Nature of Suit

Stockholders Suits

Date Filed

December 15, 2023